In line with this finding, an increase in the levels of CXCL12 and RANTES has been observed in patients with major depression, and suppression of these molecules has been found following treatment with antidepressant drugs (e.g., fluoxetine) (Shen et al., 2010). Here, CCL5 is linked to major depressive disorder.